Patent details

EP4265300 Title: COMPOSITION COMPRISING A 17 A-HYDROXYLASE/C17,20 LYASE (CYP17A1) INHIBITOR AND AN AKT INHIBITOR

Basic Information

Publication number:
EP4265300
PCT Application Number:
Type:
European Patent Granted for LU
Legal Status:
In force
Application number:
EP231757527
PCT Publication Number:
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
COMPOSITION COMPRISING A 17 A-HYDROXYLASE/C17,20 LYASE (CYP17A1) INHIBITOR AND AN AKT INHIBITOR
French Title of Invention:
COMPOSITION COMPRENANT UN INHIBITEUR DE 17 A-HYDROXYLASE/C17,20 LYASE (CYP17A1) ET UN INHIBITEUR DE AKT
German Title of Invention:
ZUSAMMENSETZUNG ENTHALTEND EINEN 17 A-HYDROXYLASE/C17,20 LYASE (CYP17A1) INHIBITOR UND EINEN AKT INHIBITOR
SPC Number:

Dates

Filing date:
01/10/2014
Grant date:
10/12/2025
EP Publication Date:
25/10/2023
PCT Publication Date:
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
10/12/2025
EP B1 Publication Date:
10/12/2025
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
Expiration date:
01/10/2034
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
03/12/2025
 
 

Name:
Novartis AG
Address:
Lichtstrasse 35, 4056 Basel, Switzerland (CH)

Inventor

1

Name:
KUMAR, Rakesh
Address:
United States (US)

2

Name:
CORNFELD, Mark J.
Address:
United States (US)

3

Name:
MORRIS, Shannon Renae
Address:
United States (US)

Priority

1

Priority Number:
201361885049 P
Priority Date:
01/10/2013
Priority Country:
United States (US)

2

Priority Number:
201461933379 P
Priority Date:
30/01/2014
Priority Country:
United States (US)

Classification

IPC classification:
A61K 31/4155; A61K 31/4375; A61K 31/58; A61K 45/06; A61P 35/00; A61P 35/04; A61P 43/00;

Publication

European Patent Bulletin

Issue number:
202550
Publication date:
10/12/2025
Description:
Grant (B1)

Annual Fees

Annual Fee Due Date:
02/11/2026
Annual Fee Number:
13
Annual Fee Amount:
180 Euro
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages